miR‐152 controls migration and invasive potential by targeting TGFα in prostate cancer cell linesChen Zhu, Changjun Yin, Xiaoxin Meng et al.|The Prostate|2013Cited by 76
miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cellsChen Zhu, Pengfei Shao, Jie Li et al.|Molecular and Cellular Biochemistry|2013Cited by 69
miR-154 inhibits prostate cancer cell proliferation by targeting CCND2Chen Zhu, Changjun Yin, Pengfei Shao et al.|Urologic Oncology Seminars and Original Investigations|2013Cited by 62
The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinomaChao Qin, Changjun Yin, Qiang Cao et al.|Scientific Reports|2016Cited by 31
Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control studyJiawei Chen, Changjun Yin, Xinhai Cui et al.|BMC Cancer|2013Cited by 24